Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study.

[1]  M. Coleman,et al.  Trends in cancer incidence and mortality. , 1993, IARC scientific publications.

[2]  Ewout W Steyerberg,et al.  Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis. , 2006, European journal of cancer.

[3]  M. Marangolo,et al.  Germ cell tumours of the testis. , 2005, Critical reviews in oncology/hematology.

[4]  H. Adami,et al.  Testicular cancer incidence in eight northern European countries: secular and recent trends. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  F Levi,et al.  Trends in cancer mortality in the European Union and accession countries, 1980-2000. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  S. Schwartz,et al.  Differences in Testis Cancer Survival by Race and Ethnicity: A Population-Based Study, 1973–1999 (United States) , 2004, Cancer Causes & Control.

[7]  P. Vasey,et al.  Part I: testicular cancer--management of early disease. , 2003, The Lancet. Oncology.

[8]  P. Vasey,et al.  Part II: testicular cancer--management of advanced disease. , 2003, The Lancet. Oncology.

[9]  T. Matsuda,et al.  Increasing incidence of testicular cancer worldwide: a review. , 2003, The Journal of urology.

[10]  E. Negri,et al.  Western and eastern European trends in testicular cancer mortality , 2001, The Lancet.

[11]  H. Møller Trends in incidence of testicular cancer and prostate cancer in Denmark , 2001, Human reproduction.

[12]  A. Majeed,et al.  Trends in testicular carcinoma in England and Wales, 1971–99 , 2001, BJU international.

[13]  L. Collette,et al.  Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. , 1999, Journal of the National Cancer Institute.

[14]  E. Feuer,et al.  Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer. , 1999, Journal of the National Cancer Institute.

[15]  G. Hédelin,et al.  Improved survival for patients with testicular cancer in Europe since 1978. EUROCARE Working Group. , 1998, European journal of cancer.

[16]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[17]  H. Adami,et al.  Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. , 1996, Journal of the National Cancer Institute.

[18]  D. Forman,et al.  Trends in incidence of testicular cancer in boys and adolescent men , 1995, International journal of cancer.

[19]  L. Einhorn,et al.  Late relapse of testicular cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  M. Coleman,et al.  Survival of cancer patients in europe—The EUROCARE study , 1995, Cancer Causes & Control.

[21]  J. Matthews,et al.  Time trends in accuracy of classification of testicular tumours, with clinical and epidemiological implications. , 1992, British Journal of Cancer.

[22]  A. Brown,et al.  Late relapse of testicular cancer. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[24]  G. Hédelin,et al.  [Survival and prognostic factors of germ cell tumors of the testis in the departments of Bas-Rhin, Isère, and Somme]. , 1999, Annales d'Urologie.

[25]  M. Tattersall,et al.  Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  P. Boyle,et al.  The impact of chemotherapy in germ cell tumours. , 1989, Cancer Surveys.

[27]  D. Cox Regression Models and Life-Tables , 1972 .